IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALFRED D BELEN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1386776847
CMS profile
334679
Location
AMHERST, NY

General Payments · PY2018–2024

$7,286.00

  • Reported across 419 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$898.81

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry NY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $898.81 52

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Vanda Pharmaceuticals Inc. $177.03 12
Neurocrine BioSciences, Inc. $111.49 6
Takeda Pharmaceuticals U.S.A., Inc. $110.49 7
IDORSIA PHARMACEUTICALS US INC $105.33 6
ABBVIE INC. $75.48 4
Teva Pharmaceuticals USA, Inc. $62.84 3
Otsuka America Pharmaceutical, Inc. $58.95 4
ITI, Inc. $47.68 3
Alkermes, Inc. $45.16 2
Axsome Therapeutics, Inc. $42.65 2
Lundbeck LLC $38.15 2
Medtronic, Inc. $23.56 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $863.64 61
PY2019 $1,053.69 69
PY2020 $1,160.62 57
PY2021 $1,045.79 55
PY2022 $976.68 58
PY2023 $1,286.77 67
PY2024 $898.81 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.59 01/24/2024 Food and Beverage Undisputed 01/23/2026 1103302364 CMS
ABBVIE INC. $21.60 03/07/2024 Food and Beverage Undisputed 01/23/2026 1103302366 CMS
ABBVIE INC. $18.89 07/16/2024 Food and Beverage Undisputed 01/23/2026 1103302368 CMS
ABBVIE INC. $17.40 10/31/2024 Food and Beverage Undisputed 01/23/2026 1103302370 CMS
Alkermes, Inc. $25.99 03/01/2024 Food and Beverage Undisputed 01/23/2026 1120465231 CMS
Alkermes, Inc. $19.17 05/17/2024 Food and Beverage Undisputed 01/23/2026 1120465233 CMS
Axsome Therapeutics, Inc. $24.07 01/22/2024 Food and Beverage Undisputed 01/23/2026 1148262609 CMS
Axsome Therapeutics, Inc. $18.58 06/12/2024 Food and Beverage Undisputed 01/23/2026 1148262607 CMS
IDORSIA PHARMACEUTICALS US INC $14.48 02/20/2024 Food and Beverage Undisputed 01/23/2026 1146768961 CMS
IDORSIA PHARMACEUTICALS US INC $21.95 03/21/2024 Food and Beverage Undisputed 01/23/2026 1146772262 CMS
IDORSIA PHARMACEUTICALS US INC $17.38 04/18/2024 Food and Beverage Undisputed 01/23/2026 1146776672 CMS
IDORSIA PHARMACEUTICALS US INC $16.30 05/21/2024 Food and Beverage Undisputed 01/23/2026 1146778625 CMS
IDORSIA PHARMACEUTICALS US INC $15.83 07/31/2024 Food and Beverage Undisputed 01/23/2026 1146788321 CMS
IDORSIA PHARMACEUTICALS US INC $19.39 09/25/2024 Food and Beverage Undisputed 01/23/2026 1146782436 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.62 04/30/2024 Food and Beverage Undisputed 01/23/2026 1143191917 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.92 07/11/2024 Food and Beverage Undisputed 01/23/2026 1143191920 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.14 09/05/2024 Food and Beverage Undisputed 01/23/2026 1143191924 CMS
Lundbeck LLC $23.05 05/01/2024 Food and Beverage Undisputed 01/23/2026 1145896261 CMS
Lundbeck LLC $15.10 07/10/2024 Food and Beverage Undisputed 01/23/2026 1145896263 CMS
Medtronic, Inc. $23.56 06/25/2024 Food and Beverage Undisputed 01/23/2026 1119296099 CMS
Neurocrine Biosciences, Inc. $13.48 02/09/2024 Food and Beverage Undisputed 01/23/2026 1150878649 CMS
Neurocrine Biosciences, Inc. $22.48 03/22/2024 Food and Beverage Undisputed 01/23/2026 1150849056 CMS
Neurocrine Biosciences, Inc. $14.49 04/20/2024 Food and Beverage Undisputed 01/23/2026 1150876370 CMS
Neurocrine Biosciences, Inc. $23.68 06/19/2024 Food and Beverage Undisputed 01/23/2026 1150844160 CMS
Neurocrine Biosciences, Inc. $18.53 08/02/2024 Food and Beverage Undisputed 01/23/2026 1150863781 CMS
Neurocrine Biosciences, Inc. $18.83 09/18/2024 Food and Beverage Undisputed 01/23/2026 1150862833 CMS
Otsuka America Pharmaceutical, Inc. $14.21 05/16/2024 Food and Beverage Undisputed 01/23/2026 1118860293 CMS
Otsuka America Pharmaceutical, Inc. $13.40 06/11/2024 Food and Beverage Undisputed 01/23/2026 1118860295 CMS
Otsuka America Pharmaceutical, Inc. $16.97 07/25/2024 Food and Beverage Undisputed 01/23/2026 1118860297 CMS
Otsuka America Pharmaceutical, Inc. $14.37 11/12/2024 Food and Beverage Undisputed 01/23/2026 1118860299 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.63 02/15/2024 Food and Beverage Undisputed 01/23/2026 1137484897 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.69 04/22/2024 Food and Beverage Undisputed 01/23/2026 1137484901 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.46 06/18/2024 Food and Beverage Undisputed 01/23/2026 1137484905 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.19 07/23/2024 Food and Beverage Undisputed 01/23/2026 1137484909 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.19 09/16/2024 Food and Beverage Undisputed 01/23/2026 1137484912 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.46 11/04/2024 Food and Beverage Undisputed 01/23/2026 1137484916 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.87 12/09/2024 Food and Beverage Undisputed 01/23/2026 1137484920 CMS
Teva Pharmaceuticals USA, Inc. $25.10 04/16/2024 Food and Beverage Undisputed 01/23/2026 1151512043 CMS
Teva Pharmaceuticals USA, Inc. $17.86 06/17/2024 Food and Beverage Undisputed 01/23/2026 1151512071 CMS
Teva Pharmaceuticals USA, Inc. $19.88 08/28/2024 Food and Beverage Undisputed 01/23/2026 1151512091 CMS
Vanda Pharmaceuticals Inc. $16.99 01/04/2024 Food and Beverage Undisputed 01/23/2026 1133896505 CMS
Vanda Pharmaceuticals Inc. $14.68 01/30/2024 Food and Beverage Undisputed 01/23/2026 1133896507 CMS
Vanda Pharmaceuticals Inc. $14.21 02/28/2024 Food and Beverage Undisputed 01/23/2026 1133896509 CMS
Vanda Pharmaceuticals Inc. $22.56 04/25/2024 Food and Beverage Undisputed 01/23/2026 1133896511 CMS
Vanda Pharmaceuticals Inc. $4.16 05/08/2024 Food and Beverage Undisputed 01/23/2026 1133896513 CMS
Vanda Pharmaceuticals Inc. $11.72 05/25/2024 Food and Beverage Undisputed 01/23/2026 1133896515 CMS
Vanda Pharmaceuticals Inc. $18.96 06/21/2024 Food and Beverage Undisputed 01/23/2026 1133896517 CMS
Vanda Pharmaceuticals Inc. $14.76 07/20/2024 Food and Beverage Undisputed 01/23/2026 1133896519 CMS
Vanda Pharmaceuticals Inc. $17.10 08/16/2024 Food and Beverage Undisputed 01/23/2026 1133896521 CMS
Vanda Pharmaceuticals Inc. $3.81 09/06/2024 Food and Beverage Undisputed 01/23/2026 1133896523 CMS
Vanda Pharmaceuticals Inc. $25.04 09/13/2024 Food and Beverage Undisputed 01/23/2026 1133896525 CMS
Vanda Pharmaceuticals Inc. $13.04 12/13/2024 Food and Beverage Undisputed 01/23/2026 1133896527 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.